Biospecimen Contract Research Services Market Size and Revenue Impact Study 2025 to 2034
Global Biospecimen Contract Research Services Market Size is valued at USD 5.0 Billion in 2024 and is predicted to reach USD 17.7 billion by the year 2034 at a 13.6% CAGR during the forecast period for 2025 to 2034.
Biospecimen Contract Research Services Market Size, Share & Trends Analysis Report By Biospecimen Type (Oncological Studies, Non-Oncological Studies), By Therapeutic Area, By Region, And By Segment Forecasts, 2025 to 2034
Increased investment in pharmaceutical R&D, an increase in the number of clinical trials, and the high cost of in-house drug development are driving growth in the Biospecimen Contract Research Services Market (encouraging pharma-biotech companies to outsource). Growth in the drugs and biologics market despite the COVID-19 pandemic, rising demand for specialized testing services among end-users, and the need for novel clinical trial designs for complex cell and gene therapies are all expected to provide a wide range of growth opportunities for market participants.
Most pharmaceutical, biopharmaceutical, and medical device companies continue to invest heavily in developing new drugs and devices. In the pharmaceutical industry, R&D is essential, and pharmaceutical firms invest in research and development to bring high-quality, innovative products to market. The increased investment in biologics and biosimilars by biopharmaceutical companies is attributed to an increase in the number of approved products globally. Biologics like proteins, peptides, and monoclonal antibodies currently account for more than half of all drug candidates in the discovery stage.
Competitive Landscape
Some Major Key Players In The Biospecimen Contract Research Services Market:
- ABS Inc.
- AllCells
- Ardent Clinical Research Services
- Asterand Bioscience (BioIVT)
- Audubon Bioscience
- BioChain
- BioChain Institute
- BioChemed Services
- BioIVT
- Bio-Options
- BioServe
- BioTalentum
- Boca Biolistics
- Capital Biosciences, Inc.
- Cellero
- Champions Oncology
- Conversant Bio (HCA Healthcare)
- Creative Bioarray
- Cureline
- Discovery Life Sciences
- Eolas Biosciences Co. Ltd
- Geneticist (Genomic Expression)
- GR BioResearch
- iProcess Global Research Inc.
- ICON plc
- Indivumed GmbH
- Infinity BiologiX
- iSpecimen
- Labcorp Drug Development (Covance)
- Medicover
- National BioService
- Precision for Medicine, Inc.
- PrecisionMed, Inc.
- ProMedDx
- REPROCELL
- SeraCare (LGC Clinical Diagnostics)
- STEMCELL Technologies
- The MT Group
- Tissue Solutions (Exact Sciences)
- Trans-Hit Bio (Azenta US, Inc.)
- ZenBio
Market Segmentation:
The Biospecimen Contract Research Services market is segmented into the biospecimen types and therapeutics areas. Based on the type of biospecimen types, the market is segmented into oncological and non-oncological studies. The oncological studies are further segmented into FFPE Tissue, Frozen Tissue, Plasma / Serum and Other Biospecimens. The non-oncological studies are further segmented into Blood Products, Human Tissue and Other Biospecimens. The therapeutics area segment includes Oncological Disorders, Neurological Disorders, Cardiovascular Disorders and Other Therapeutic Areas.
Based on Biospecimen Type, the oncological studies segment is accounted as a significant contributor in the Biospecimen Contract Research Services market.
The oncological studies segment is accounted as a significant contributor in the Biospecimen Contract Research Services market. The demand for biospecimens in cancer research has increased, but there is little data on biospecimen usage trends. These data are required to forecast future demand. This was due to larger cohort sizes for both frozen and FFPE tissues. For decades, Formalin-Fixed Paraffin-Embedded (FFPE) tissue specimens have been a mainstay of research and therapeutic applications. FFPE is a type of biopsy specimen preservation and preparation that aids in the examination, experimental research, and diagnostic/drug development. To preserve the proteins and vital structures within the tissue, a tissue sample is first fixed in formaldehyde, also known as formalin. It is then embedded in a paraffin wax block, making it easier to cut slices of the required sizes for examination on a microscopic slide.
The Oncological Disorders Segment Witnessed Growth At A Rapid Rate.
Oncology, or the study of cancer and tumours, has made significant advancements in the prevention, treatment, and prognosis of many childhood cancers. Despite this progress, cancer remains the leading cause of death in children. Childhood cancer differs from adult cancers in terms of development, treatment, response to therapy, therapy tolerance, and prognosis. In most cases, childhood cancer responds better to treatment, the child can tolerate more aggressive treatment, and the forecast is better.
The North America Biospecimen Contract Research Services Market Holds A Significant Revenue Share In The Region.
North America dominated the global biospecimen contract research services market. North America's dominance in this market is primarily due to the market's rapid growth, pharmaceutical and biopharmaceutical companies' increased focus on outsourcing, and an increase in the number of clinical trial activities in the region. The rising popularity of precision/personalized medicine and genetic testing has been a major driving force in the region's market. Biobanks have long been essential in biomedical research. Over the last few decades, there have been several advancements in the platforms and tools used in genetic studies. This has resulted in increased clinical lab demand for biospecimens to develop assays for genetic testing in this region.
Recent Developments:
- In July 2023, Discovery Life Sciences (Discovery) introduced clinical trial services utilizing cutting-edge flow cytometry technology. Discovery incorporated Cytek Aurora instruments, in addition to its molecular pathology, genomics, and proteomics services, into a single facility. This action further ensured the quality of pharmaceutical and diagnostic development while saving valuable time. The utilization of full-spectrum technology in Cytek Aurora instruments granted researchers an unparalleled level of flexibility.
- In Jan 2023, CRO Crown Bioscience acquired the Biospecimens Service Unit from Indivumed. With access to the biospecimens through a multiyear collaboration with Crown Bioscience, IndivuType converted them into multiomics data in order to inform the development of personalized cancer drugs powered by artificial intelligence and data.
The Biospecimen Contract Research Services Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 5.0 billion |
| Revenue Forecast In 2034 | USD 17.7 billion |
| Growth Rate CAGR | CAGR of 13.6 % from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Biospecimen Type, By Therapeutic Area |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; India; Japan; Brazil; Mexico ; France; Italy; Spain; China; South Korea; South East Asia |
| Competitive Landscape | BioChain Institute, BioIVT, Boca Biolistics, Creative Bioarray, Cureline, Discovery Life Sciences, Infinity BiologiX, Precision for Medicine, Inc., PrecisionMed, Inc., Medicover, National BioService, ICON plc, The MT Group, Eolas Biosciences Co. Ltd, Indivumed GmbH, Ardent Clinical Research Services, Capital Biosciences, Inc., GR BioResearch, REPROCELL, Trans-Hit Bio (Azenta US, Inc.) and iSpecimen |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Biospecimen Contract Research Services Market-
By Service Type
- Procurement Services
- Custom donor recruitment
- Disease-specific collections
- Processing & Storage
- Cryopreservation
- Biobanking
- Analytical Services
- QC/QA testing
- Biomarker isolation
- Distribution & Logistics
- Cold-chain management
- Global shipping
By Specimen Type
- Human Tissues
- FFPE
- Frozen/Fresh
- Biofluids
- Plasma/Serum
- CSF/Urine
- Cells
- PBMCs
- Stem Cells
- Molecular
- DNA/RNA
- Exosomes
By Therapeutic Area
- Oncology (Tumors, TILs)
- Neurology (Brain tissue, CSF)
- Infectious Diseases (PBMCs, Serology)
- Rare Diseases (Niche biospecimens)
By End-User
- Pharma/Biotech
- Academic Institutes
- Diagnostic Labs
By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Biospecimen Contract Research Services Market is expected to grow at a 13.6% CAGR during the forecast period for 2025 to 2034
BioChain Institute, BioIVT, Boca Biolistics, Creative Bioarray, Cureline, Discovery Life Sciences, Infinity BiologiX, Precision for Medicine, Inc.
Biospecimen Contract Research Services Market Size is valued at USD 5.0 Bn in 2024 & is predicted to reach USD 17.7 Bn by the year 2034
Biospecimen Contract Research Services market is segmented into the biospecimen types and therapeutics areas.
North American region is leading the Biospecimen Contract Research Services Market